Strategy Asset Managers LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 200.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,246 shares of the medical equipment provider’s stock after purchasing an additional 8,174 shares during the quarter. Strategy Asset Managers LLC’s holdings in Intuitive Surgical were worth $4,469,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of ISRG. CWM LLC increased its position in shares of Intuitive Surgical by 200.0% in the fourth quarter. CWM LLC now owns 285 shares of the medical equipment provider’s stock valued at $104,000 after acquiring an additional 190 shares during the period. American National Bank increased its position in shares of Intuitive Surgical by 200.0% in the fourth quarter. American National Bank now owns 300 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 200 shares during the period. ETF Managers Group LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at about $110,000. Trust Department MB Financial Bank N A increased its position in shares of Intuitive Surgical by 200.0% in the fourth quarter. Trust Department MB Financial Bank N A now owns 345 shares of the medical equipment provider’s stock valued at $126,000 after acquiring an additional 230 shares during the period. Finally, Cerebellum GP LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $127,000. Institutional investors own 36.79% of the company’s stock.
A number of equities analysts have issued reports on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $409.00 price objective on the stock in a research report on Wednesday, January 3rd. Wells Fargo & Co reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Monday, October 16th. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. Goldman Sachs Group reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th. Finally, Vetr upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 price target on the stock in a research report on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $408.48.
In other news, Director Mark J. Rubash sold 6,000 shares of the company’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $395.95, for a total value of $2,375,700.00. Following the transaction, the director now owns 5,453 shares in the company, valued at $2,159,115.35. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Gary S. Guthart sold 28,525 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $414.50, for a total transaction of $11,823,612.50. Following the completion of the transaction, the chief executive officer now owns 311,469 shares in the company, valued at approximately $129,103,900.50. The disclosure for this sale can be found here. Insiders have sold 85,016 shares of company stock worth $35,133,026 in the last three months. 2.20% of the stock is currently owned by insiders.
Intuitive Surgical, Inc. (NASDAQ ISRG) traded down $2.87 during trading hours on Tuesday, reaching $395.64. 138,870 shares of the company traded hands, compared to its average volume of 1,013,417. Intuitive Surgical, Inc. has a 1-year low of $236.75 and a 1-year high of $452.00. The company has a market capitalization of $44,560.00, a price-to-earnings ratio of 69.65, a P/E/G ratio of 4.63 and a beta of 0.50.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, topping the consensus estimate of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The business had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. During the same quarter in the previous year, the firm posted $2.03 earnings per share. Intuitive Surgical’s quarterly revenue was up 17.9% on a year-over-year basis. analysts expect that Intuitive Surgical, Inc. will post 7.93 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: “Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Strategy Asset Managers LLC” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/13/strategy-asset-managers-llc-grows-stake-in-intuitive-surgical-inc-isrg.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.